NCT06638827

Outcome Of Bilateral Thoracoscopic Sympathectomy for Patients With Primary Focal Hyperhidrosis

Outcome Of Bilateral Thoracoscopic Sympathectomy for Patients With Primary Focal Hyperhidrosis, Sohag University Hospital Experience

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 100 (estimated)
• Sponsor: Sohag University · Academic / Other
• Sex: All
• Age: 15 Years
• Healthy volunteers: Accepted

Summary

The goal of this clinical trial is to examine the overall efficiency of Bilateral Thoracoscopic Sympathectomy on the permanent reduction of Primary focal hyperhidrosis of predilective parts of the body, palms, armpits, face, and soles.

Detailed description

The aims of this study are: 1. examine the efficiency of Bilateral Thoracoscopic Sympathectomy (BTS) with different levels of transection among the persons with the Primary focal Hyperhidrosis (PFH) 2. examine the influence of BTS on cardio-pulmonary function tests in persons with PFH after the operation. 3. examine the incidence, duration, and intensity of compensatory sweating after BTS among persons with PFH 4. examine the incidence, duration, localization, and treatment of postoperative pain after BTS among persons with PFH. 5. determine postoperative complications of BTS among persons with PFH 6. examine the influence of BTS on quality of life among persons with PFH

Conditions

• Hyperhidrosis Primary Focal Palms

Interventions

Type	Name	Description
PROCEDURE	Thoracic Sympathectomy	Bilateral thoracoscopic sympathectomy will be performed with general anesthesia, using single lung ventilation and monopolar cautery for transection of the sympathetic chain. Persons with PFH who underwent the BTS were classified into three groups, depending the level of transaction of sympathetic chain: 1. transection at the level from the second to the forth thoracic sympathetic ganglion (T2- T4); 2. transection at the level from the third to the forth thoracic sympathetic ganglion (T3-T4) 3. transection at the level from the second to the third thoracic sympathetic ganglion (T2-T3)..

Timeline

• Start date: 2024-01-01
• Primary completion: 2025-04-01
• Completion: 2025-06-01
• First posted: 2024-10-15
• Last updated: 2024-10-15

Locations

1 site across 1 country: Egypt